ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36895
-0.02%
Bitcoin
64,316.09
0.50%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFM)

  7. Sunshine Biopharma Inc (SBFM) News

SBFM Sunshine Biopharma Inc

0.858
0.0205 (2.45%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sunshine Biopharma Inc SBFM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0205 2.45% 0.858 23:00:08
Open Price Low Price High Price Close Price Previous Close
0.9227 0.81 0.9227 0.84 0.8375
more quote information »

Recent News

Date Time Source Heading
3/06/202415:05EDGAR2Form 8-K - Current report
3/05/202415:37EDGAR2Form PRE 14C - Other preliminary information statements
3/05/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202415:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202415:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202407:24EDGAR2Form PRE 14C - Other preliminary information statements
2/16/202416:01EDGAR2Form 8-K - Current report
2/15/202410:39EDGAR2Form 8-K - Current report
2/14/202414:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202410:18EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2/12/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/12/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202408:04EDGAR2Form 8-K - Current report
2/09/202416:17EDGAR2Form S-1/A - General form for registration of securities..
2/01/202415:17EDGAR2Form S-1 - General form for registration of securities under..
1/30/202411:38EDGAR2Form 8-K - Current report
1/08/202407:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/07/202315:59EDGAR2Form 8-K - Current report
12/04/202307:30GLOBESunshine Biopharma Moves Principal Office to New York City
11/13/202308:00EDGAR2Form 8-K - Current report
11/13/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202311:18EDGAR2Form 8-K - Current report
10/20/202312:06EDGAR2Form 8-K - Current report
10/19/202311:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/18/202312:32EDGAR2Form DEF 14A - Other definitive proxy statements
10/13/202309:44EDGAR2Form 8-K - Current report
9/05/202315:20EDGAR2Form DEF 14A - Other definitive proxy statements
8/25/202314:16EDGAR2Form PRE 14A - Other preliminary proxy statements
8/11/202308:00EDGAR2Form 8-K - Current report
8/11/202307:30GLOBESunshine Biopharma Reports 2023 Second Quarter Results:..
8/10/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/16/202308:58GLOBESunshine Biopharma Announces Closing of $5.0 Million Private..
5/12/202307:00GLOBESunshine Biopharma Announces Pricing of $5.0 Million Private..
5/11/202308:00GLOBESunshine Biopharma Reports 2023 First Quarter..

Your Recent History

NASDAQ
SBFM
Sunshine Biopharma
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved